Prof Claudio Ronco, MD, FERA is an expert in Nephrology at Ospedale San Bortolo (Italy). As of November 2026, ScienceLeadR ranks Claudio Ronco in the top 1% of experts worldwide for Renal Insufficiency, Critical Illness and Heart Failure. Claudio Ronco has authored 1,927 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 2 of them ongoing. SLR score: 6,308 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Claudio Ronco, MD, FERA Ospedale San Bortolo Italy
6 308 ScienceLeadR Reputation 6308
Network Map

Nephrology

Subspecialties: Hematology - Transplantation - Critical Care

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026

Source: PubMed

Ospedale San Bortolo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1927

Citations

Citations: 96 660 1st author: 278 Last author: 863 Unique author: 117


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Redefining Cardiometabolic Disease: Expert Consensus on the CardioVascular-Kidney-Liver-Metabolic (CVKLM) Multiorgan Staging.
PMID 42945405 — liver diseases, diabetes mellitus, heart, cardiovascular diseases, kidney, liver, obesity, therapeutics
Eur J Prev Cardiol20260
Artificial Intelligence-Guided Extracellular Vesicle Platforms for Diagnosis and Treatment of Chronic Kidney Disease: A Scoping Review and Future Directions.
PMID 42942409 — kidney diseases, extracellular vesicles, intelligence, kidney, biomarkers, machine learning, exosomes, precision medicine, diagnosis, therapeutics, artificial intelligence
Medicina (Kaunas)20260
Best Practices in Performing CRRT during ECMO: Workgroup Statements from the Joint Acute Disease Quality Initiative (ADQI) and Extracorporeal Life Support Organization (ELSO) Consensus Conference on ECMO, AKI, Fluid Management and CRRT.
PMID 42862784 — extracorporeal membrane oxygenation, renal dialysis, acute disease
Blood Purif20260
Cardiovascular-Kidney-Metabolic Syndrome: Is the Evidence Keeping Pace with the Concept?
PMID 42758649 — heart diseases, kidney, metabolic syndrome
Cardiorenal Med20260
Hemoadsorption/Hemodialysis: Rationale, Indications, and Practical Application.
PMID 42721092 — kidney diseases, phenotype, kidney, therapeutics
Contrib Nephrol20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Director: 6

By phase:

N/A 16
Phase 4 3
Phase 1 1
Phase 2 1

By status:

Completed 15
Recruiting 2
Terminated 2
Active not recruiting 1
Enrolling by invitation 1

By type:

Observational 12
Interventional 9

By Monocentric/Multicentric:

monocentric 15
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
ICHARUS Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms
NCT07522008 — registries, kidney diseases, quality of life, safety, cohort studies, prescriptions, kidney, maintenance, signs and symptoms, uremia, patient reported outcome measures, bronchiolitis obliterans, bronchiolitis, bronchiolitis obliterans syndrome
N/ARecruiting2026
Adaptive Blood Purification for the Treatment of Patients With Septic Shock
NCT06692036 — mortality, blood, shock, septic, kidney, therapeutics, renal replacement therapy, acute kidney injury, plasma
N/AEnrolling by invitation2025

LeadR Networks

Main global connection map